Results 251 to 260 of about 191,557 (278)

Genetically Modified Mesenchymal Stromal/Stem Cells as a Delivery Platform for SE-33, a Cathelicidin LL-37 Analogue: Preclinical Pharmacokinetics and Tissue Distribution in C57BL/6 Mice. [PDF]

open access: yesAntibiotics (Basel)
Gasanov VAO   +8 more
europepmc   +1 more source

RNA Selectively Modulates Activity of Virulent Amyloid PSMα3 and Host Defense LL-37 via Phase Separation and Aggregation Dynamics

open access: yes
Rayan B   +11 more
europepmc   +1 more source

Cathelicidin LL-37: A Multitask Antimicrobial Peptide

Archivum Immunologiae et Therapiae Experimentalis, 2010
The antimicrobial peptide LL-37 is the only known member of the cathelicidin family of peptides expressed in humans. LL-37 is a multifunctional host defense molecule essential for normal immune responses to infection and tissue injury. LL-37 peptide is a potent killer of different microorganisms with the ability to prevent immunostimulatory effects of ...
Robert, Bucki   +3 more
openaire   +3 more sources

Cathelicidin LL-37 Expression in Human Breast Implant Capsules

Plastic & Reconstructive Surgery, 2023
Background: Capsular contracture is the most common complication following breast implant placement. Cathelicidin LL-37 is a cationic peptide involved in innate immunity. Initially investigated for its antimicrobial role, it was found to have pleiotropic activities, such as immunomodulation, angiogenesis stimulation, and tissue
Francesco, Segreto   +9 more
openaire   +2 more sources

The chemistry and biology of LL-37

Natural Product Reports, 2009
LL-37 is a human host defence peptide that has a wide range of biological functions, including antimicrobial and immunomodulatory properties. This review summarises how molecular structure influences the balance between the immunomodulatory and antimicrobial functions of LL-37.
Matthew F, Burton, Patrick G, Steel
openaire   +2 more sources

Home - About - Disclaimer - Privacy